Clincosm LogoSign in Get a demo

Chronic Hepatitis B

Showing 26 - 50 of 400
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis b, Anti-PD-1 Antibody Trial in Chongqing (Anti-PD-1 antibody, NAs)

Not yet recruiting
  • Chronic Hepatitis b
  • Anti-PD-1 Antibody
  • Anti-PD-1 antibody
  • NAs
  • Chongqing, Chongqing, China
    The 2nd affiliated Hospital of Chongqing Medical University
Mar 3, 2023

Hepatic Inflammation, Fibrosis and Prognosis in CHB and NAFLD

Recruiting
  • Chronic Hepatitis b
  • Non-alcoholic Fatty Liver Disease
    • Nanjing, China
      Nanjing Drum Tower Hospital
    Mar 2, 2023

    Chronic Hepatitis B Trial (RO7565020, Placebo, Nucleos(t)ide analogue (NUC) treatment)

    Not yet recruiting
    • Chronic Hepatitis B
    • (no location specified)
    Feb 28, 2023

    Chronic Hepatitis b Trial in Beijing, Chongqing (STSG-0002 Injection)

    Not yet recruiting
    • Chronic Hepatitis b
    • STSG-0002 Injection
    • Beijing, Beijing, China
    • +3 more
    Mar 6, 2023

    Chronic Hepatitis b Trial in Beijing, Chongqing (STSG-0002 Injection)

    Not yet recruiting
    • Chronic Hepatitis b
    • STSG-0002 Injection
    • Beijing, Beijing, China
    • +3 more
    Mar 6, 2023

    TMF in the Treatment of CHB Patients With Low-level Viraemia

    Not yet recruiting
    • Chronic Hepatitis B
    • Chongqing, Chongqing, China
    • +14 more
    Mar 3, 2023

    Chronic Hepatitis b Trial in Guangzhou (Vitamin D)

    Completed
    • Chronic Hepatitis b
    • Vitamin D
    • Guangzhou, Guangdong, China
      Department of Infectious Diseases, The Third Affliated Hospital
    Mar 2, 2023

    Chronic Hepatitis B Trial in Hamburg (HEPLISAV B; TherVacB, TherVacB)

    Not yet recruiting
    • Chronic Hepatitis B
    • HEPLISAV B; TherVacB
    • TherVacB
    • Hamburg, Germany
      CTC North
    Feb 3, 2023

    Hepatocellular Carcinoma, Chronic Hepatitis B Trial in Xiamen (NAs("Entecavir"or"Tenofovir"or"Tenofovir alafenamide") combined

    Recruiting
    • Hepatocellular Carcinoma
    • Chronic Hepatitis B
    • NAs（"Entecavir"or"Tenofovir"or"Tenofovir alafenamide"） combined with interferon treatments
    • NAs （"Entecavir"or"Tenofovir"or"Tenofovir alafenamide"） treatments
    • Xiamen, Fujian, China
      Boheng Zhang
    Feb 7, 2023

    Chronic Hepatitis B Trial in Grafton (AHB-137 injection, Placebo)

    Not yet recruiting
    • Chronic Hepatitis B
    • AHB-137 injection
    • Placebo
    • Grafton, Auckland, New Zealand
      New Zealand Clinical Research
    Jan 29, 2023

    Metabolic Syndrome on Antiviral Response in People With Chronic

    Not yet recruiting
    • Chronic Hepatitis b
      • (no location specified)
      Jan 21, 2023

      Chronic Hepatitis B Trial in Worldwide (Bepirovirsen, Placebo)

      Recruiting
      • Chronic Hepatitis B
      • Victoria, British Columbia, Canada
      • +10 more
      Jan 23, 2023

      Chronic Hepatitis B Trial (Bepirovirsen, Placebo)

      Recruiting
      • Chronic Hepatitis B
      • Herston, Queensland, Australia
      • +7 more
      Jan 23, 2023

      Chronic Hepatitis B, High-Risk Cancer Trial in China (Peginterferon alfa-2b Injection, Nucleos (t) ide Analogue, Nucleos(t)ide

      Active, not recruiting
      • Chronic Hepatitis B
      • High-Risk Cancer
      • Peginterferon alfa-2b Injection, Nucleos (t) ide Analogue
      • Nucleos(t)ide analogue
      • Chengdu, China
      • +8 more
      Jan 4, 2023

      Chronic Hepatitis B Trial in Monterey Park (NCO-48 Fumarate 4 mg, NCO-48 Fumarate 20 mg, Tenofovir Alafenamide 25 mg)

      Completed
      • Chronic Hepatitis B
      • NCO-48 Fumarate 4 mg
      • +2 more
      • Monterey Park, California
        National Institute of Clinical Research, Inc
      Jan 3, 2023

      Chronic Hepatitis B Trial (HRS5091 Tablets, Midazolam Maleate Tablets, Warfarin Sodium Tablets)

      Completed
      • Chronic Hepatitis B
      • HRS5091 Tablets
      • +6 more
      • Guangzhou, Guangdong, China
        The Second Affiliated Hospital of Guangzhou Medical University
      Dec 22, 2022

      HBeAg-negative CHB Patients With Indeterminate Phase

      Recruiting
      • Chronic Hepatitis b
      • Observation
      • Antiviral treatment
      • Changzhou, Jiangsu, China
      • +4 more
      Dec 21, 2022

      Chronic Hepatitis B Trial in Hong Kong (Tenofovir alafenamide(TAF), Tenofovir disoproxil fumarate(TDF))

      Recruiting
      • Chronic Hepatitis B
      • Tenofovir alafenamide(TAF)
      • Tenofovir disoproxil fumarate(TDF)
      • Hong Kong, Hong Kong
        Humanity and Health GI and Liver Centre
      Dec 19, 2022

      Chronic Hepatitis B Trial (ABI-4334 Tablet, ABI-4334 Placebo)

      Recruiting
      • Chronic Hepatitis B
      • ABI-4334 Tablet
      • ABI-4334 Placebo
      • Grafton, Auckland, New Zealand
        New Zealand Clinical Research
      Dec 12, 2022

      Chronic Hepatitis B Trial in Worldwide (ABI-H3733, Placebo)

      Recruiting
      • Chronic Hepatitis B
      • Sofia, Sofia City, Bulgaria
      • +10 more
      Dec 12, 2022

      Chronic Hepatitis b Trial in Changchun (GST-HG141)

      Recruiting
      • Chronic Hepatitis b
      • Changchun, Jilin, China
        The first hospital of Jilin University
      Dec 5, 2022

      Chronic Hepatitis B Trial in Worldwide (ALG-000184, Placebo)

      Recruiting
      • Chronic Hepatitis B
      • Guangzhou, Guangdong, China
      • +5 more
      Nov 17, 2022

      Chronic Hepatitis B Trial in Worldwide (ALG-125755, Placebo)

      Recruiting
      • Chronic Hepatitis B
      • Sofia, Bulgaria
      • +3 more
      Oct 28, 2022

      System of Clinical Endpoint Events for Chronic Hepatitis B

      Active, not recruiting
      • Chronic Hepatitis b
        • Beijing, Beijing, China
        • +6 more
        Sep 2, 2022

        Significant Liver Fibrosis and Inflammation in Chronic HBV

        Not yet recruiting
        • Chronic Hepatitis b
          • (no location specified)
          Aug 7, 2022